艾美捷科技代理JGFInneran品牌。

JGFInneran在生物技术和实验室设备领域具有显著优势，凭借高质量产品和定制化服务，赢得了广泛的市场认可。JGFInneran提供先进的控制系统，实现精确的温度、pH、溶氧控制；采用高质量材料，使用不锈钢和玻璃等耐腐蚀材料，确保设备耐用；自动化与数据记录: 支持自动化操作和实时数据记录，便于实验监控和分析。应用领域包括：生物制药: 用于单克隆抗体、疫苗等生产；生物燃料: 用于微生物发酵生产乙醇等；食品与饮料: 用于发酵工艺优化；学术研究: 为科研机构提供实验设备。

JGFInneran公司主要产品包括：

（1）生物反应器：用于细胞培养和发酵，广泛应用于生物制药、疫苗生产和生物燃料开发。

（2）发酵罐：适用于微生物和细胞培养，具备高精度控制和自动化功能。

（3）实验室设备：提供搅拌器、泵、传感器等，满足实验室的多样化需求。

（4）定制解决方案：根据客户需求，提供定制化的生物反应器和发酵罐。

BiosPacific公司是R&D Systems 旗下专门为临床诊断试剂的研发与生产提供抗原、抗体（多抗、单抗、偶联的抗体、抗体对）的公司，在临床诊断试剂方面非常著名，是临床诊断试剂原料的全球供应商。BiosPacific公司是全球著名的临床诊断抗原抗体原料的供应商，其产品主要集中在癌症（肿瘤）、内分泌、传染病、人血清蛋白、甾类、血管病等标记物的优质单抗、多抗、抗原、偶联抗体，以及抗体对（matched pairs）。

As a manufacturer and supplier of antibodies and antigens of exceptional quality, for more than 29 years, BiosPacific is experienced in meeting the rigorous demands of the industrial client. Our success has been due, in large part, to our commitment to find the most effective solutions for your individual needs. Our expansive range of monoclonal antibodies, affinity purified polyclonal antibodies and purified proteins for immunoassay development allows us to support our customers collaboratively from feasibility to manufacturing. Browse by subject category such as cancer or cardiac markers below, or do a keyword search using the search field above.

BIOSPACIFIC产品的主要涵盖领域：

（1）Cancer

AFP, Alpha-2 Macroglobulin, Beta-2 Microglobulin, CA 125

（2）Endocrine Thyroid

ACTH, FSH, hCG, hGH, IGF-1, Insulin, LH, Proinsulin

（3）Steroids

Cortisol, Estradiol, Progesterone, Testosterone

（4）Cardio-vascular

CKBB, CKMB, CKMM, CRP, D-dimer, Myoglobin, TNI

（5）Human Serum Proteins

Albumin, Alpha-1 Antitrypsin, APO E,CRP, Hemoglobin

（6）Miscellaneous

Ferritin, Glucagon, IgE Myeloma Plasma, Stripped Serums, TPO

（7）Drugs

Amikacin, Amphetamine, Barbiturate, Benzodiazepine

（8）Infectious Diseases

Adenovirus, Chlamydia, CMV, Influenza A & B, HAV, HBcAg, Zika

（9）Medix Biochemica

AFP, CEA, CKMB, IgA, Myoglobin, RSV, SHBG, TSH

Dendritics公司主要关注人类树突状细胞，希望找到能够促使CD34+造血前体细胞转化为树突状细胞（在GM-CSF和TNF-alpha存在的情况下）的细胞因子。在1992-2005年间，大量的研究使得研究者对人类树突状细胞的产生、细胞通路、C-type凝集素受体的功能及Toll-like受体的活性有了更深的理解。

DENDRITICS was started in 2005 by former members of SCHERING PLOUGH Laboratory for Immunological Research (LIR) in Dardilly, France. From their long experience at LIR, the team members of DENDRITICS have gathered complementary scientific and technological knowledge in different areas of immunology. The initial focus of LIR was in the biology of B lymphocytes, elaboration of human monoclonal antibodies, and in cytokine discovery (IL-3, IL-4, IL-7, IL-10, IL-17, GM-CSF) together with our colleagues of DNAX Research Institute in Palo Alto, California.

Our interest in cytokines led to the finding that human dendritic cells (DCs) could be generated in vitro from CD34+ hematopoietic progenitors cultured in the presence of GM-CSF and TNF-alpha.

The period from 1992 to 2005 saw the specialization of LIR in DC biology and was fuelled by a large-scale effort to discover and study the function of genes specifically expressed by these cells. This program led to a number of findings that contributed in particular to understanding the heterogeneity of DCs, the pathways regulating DC migration, the function of C-type lectin receptors in DCs and the activity of Toll-like receptors in DCs. Many novel genes were discovered through screening of cDNA libraries or through monoclonal antibodies raised against DCs.

更多详情请联系 

艾美捷科技有限公司

全国服务热线：400-6800-868

邮箱：sales@amyjet.com

网站：www.amyjet.com